Contact
Please use this form to send email to PR contact of this press release:
Prevail Therapeutics Announces IND Active for PR001 for Treatment of Neuronopathic Gaucher Disease
TO:
Please use this form to send email to PR contact of this press release:
Prevail Therapeutics Announces IND Active for PR001 for Treatment of Neuronopathic Gaucher Disease
TO: